One ERC-funded postdoc position in Molecular Pediatric Oncology lab, led by PI Daniel Bexell. The group is working with neuroblastoma (NB), a severe childhood cancer. The overall aims are to unravel mechanisms leading to metastasis and treatment resistance of NB, and to test compounds targeting aggressive NB. The post-doc will lead and develop his/her own analyses and projects, and also work in close collaboration with the rest of the team members, including our bioinformatician.
One postdoc scholarship in Immuno-Oncology group, led by PI Charlotte Rolny. Over the years, Rolny and colleagues have demonstrated that reprogramming the pro-tumor phenotype of TAMs into an anti-tumor Page 2(3) phenotype represents a promising anti-cancer strategy. The postdoctoral project will investigate downstream targets of this pathway to identify novel strategies for reprogramming TAMs in experimental models as well as patient samples.